インタビューフォーム
Contents
1.2. IV 1 1 IV
3. 11 1 2
4. 3 5 6 PD 2 5
5. 95 99 5 95 NRN 0 99 5 95
6. 63 2 IF IF 10 9 3 IF 10 20 9
7. pH pH6 8 7 8 4 pH 5 PD 2 PD 2 V 3 6 50 26 22 0 14 0 12 0
8. 2 3 30 10 11 HCa HCa HCa 1 5 2 5 4 25 ES 2 000mL 4 QO 2 500mL 4 O 5 000mL 2 HCa 1 5 HCa 2 5 1 000mL 6 QO 1 500mL 5 2 000mL 4 QO
9. 6 1 2 3 7 8 VIII 1 2
10. 1 2 3 4 2 5 6 7 2 29 3 5 8 9 10 11 12 13
11. Ca 4 25 37 2 C pH 2 12mg L 1 20mg7Lss 10 1 250mg L 12mg L 20mgt 1 Lins il RR OU 2 125mg L 11 1 125mg L 125mg L 125mg L RA ONE GR OV 4 125mg L 12 1 50mg L Be 50mg L a RU rout Rh 2270IU Rg 22701U7L 13 1 25mg L
12. 2 000mL 1mL 5 SEP CAPD
13. I F IF 2013 4 1 1 WI 20 1 err 1 1 ee 20 2 ee 1 2 20 3 20 I I 0 et 2 4
14. 3s 2
15. 5 7 29 50 26 22 0 14 0 12 0 10 0 22 3 4
16. 5 1 5 a NN pH 50 26 52 0 74 REG 042 40 4 10 0 5 CUST 016
17. pH 7 51 7 57 7 54 7 56 7 56 208 0 204 6 168 6 175 7 123 6 100 98 4 81 1 84 5 59 4 9 1030 5D pH 7 48 7 53 7 58 7 60 7 62 101 7 pH 7 47 7 59 7 62 7 66 7 68 60 5 39 5 23 7 12 6 6 1 pH 7 45 7 44 7 54 7 50 7 69 88 4 84 9 88 0 87 5 88 5 100 96 0 99 5 99 0 100 1 2 6 12 24
18. 9 1 3 86 w v 2 MTT 3 4 5 2 2 5 2H 3 IL 18 1 4 IL 6 6 28 X 1 2 2 10
19. pH 7 66 7 59 7 60 7 63 7 64 100 0 100 6 100 1 100 2 70 14 2 pH 7 54 7 57 7 57 7 62 7 66 99 8 100 1 100 0 100 1 100 0 10 11 12 13 14 2 6 12 24 0 15 1 pH 7 54 7 60 7 60 7 63 7 73 a 232 7 236 2 196 7 1894 1164 no 101 5 84 5 81 4 50 0 15 2 pH 7 59 7 65 7 63 7 66 7 68 i 232 3
20. 1 5 60kg 2L 2 1 000mL lt gt UV 1 2 3 4 5 6 uw 3 1 2
21. 300mL lt gt 1 HCa 1 5 1kg 1 3 4 HCa 2 5 1kg 1 1 4 HCa 1 5 GE LU 1kg 1 1 2 HCa 1 5 2 2 5L 2 CAPD
22. IF IF 2013 IF IF IF IF
23. pH 7 42 744 7 54 ze5 769 a 81 8 900 879 890 880 100 10 0 07 5 08 8 07 6 a 100 6 7 1 pH 7 45 7 46 7 58 7 63 7 63 a 121 4 113 9 101 7 878 205 oo 93 g 83 8 72 3 58 1 9 pH 749 751 756 764 1 767 a 115 5 98 4 108 3 834 68 8 Go 85 2 93 8 72 2 59 6 99 8 8 1 pH 7 46 7 52 7 55 7 71 7 72 EE 1177 117 5 1143 976 234 oo 99 8 971 82 9 19 9 pH 744 89 54 226 74 a 118 5 1153 107 943 223 Go 97 3 93 4 79 6 18 8
24. 5 HMF 60 2 C 40 5 RH 6 5 HMF 120 lux hr 5 5 HMF 37 2C 24 60 5 RH 0 24 7 HCa 4 25
25. 17 18 PD 2 1 5 2 5 PD 2 4 25 1 2 3 4
26. 11 1 pH 7 40 7 51 7 64 7 68 7 66 00 973 959 32 62 2 11 2 pH 7 44 7 46 7 59 7 64 7 61 100 973 972 78 8 63 98 6 20 12 1 pH 7 67 7 49 7 59 7 58 7 68 10o aga 532 242 G2 9 pH 7 51 7 54 7 62 7 66 7 61 10o 54 571 233 G4 99 0 1 Me pH 7 50 7 57 7 61 7 63 7 74 99 7 98 3 96 9 95 4 2 13 2 pH 7 44 7 55 7 56 7 59 7 66 100 1 98 9 97 5 96 8 100 4
27. 107 18 3 6 16 uu HOT 9 p 5 2 500mL 122997401 3420433A4023 622299701 HCa 1 5 5 000mL 122998101 3420433A5020 622299801 1 000mL 122994301 3420433A1024 622299401 HCa 1 5 1 500mL 122995001 3420433A2020 622299501 GOOmL 22996701 3420433A3027 622299601 2 500mL 123002401 3420434A4028 622300201 HCa 2 5 5 000mL 123003101 3420434A5024 622300301 1 000mL 122999801 3420434A1029 622299901 Ha 25 1500mL 123000001 3420434A2025 622300001 1 GOOmL 23001701 3420434A3021 622300101 HCa 4 25 2 000mL 123014701 3420435A1023 622301401 17 32 XI 1 2 1 3 294 295
28. IF IF MR IF IF IF 4 IF
29. 5 IV 5 1 2 1 1 5 2L 4 8 1 1kg 1 HCa 1 5 3 4 1kg HCa 2 5 1 4 HCa 4 25 1 2 HCa 1 5 1 3 5
30. OH CaHzO 180 16 CaHsNaO 112 06 CaCb 2H O 147 01 MgCb 6H O 203 30 NaCl 58 44 HCI 36 46 NaHCO3 84 01 NaOH 40 00 BLR350 CAS 50 99 7 72 17 3 10035 04 8 7791 18 6 7647 14 5 7647 01 0 144 55 8 1310 73 2 lI 1 1 2 3 4 5 6 7
31. 2 0L 2 5L 34 2 1 2 Physioneal 35 Physioneal 35 Physioneal 35 1 800 1 400mL m 35 45mL kg Physioneal 35 CLEARFLEX 1 600mL XIII
32. 4 5 PD 2 1 5 2 5 PD 2 4 25 uw V 1 2 3 4
33. CRP X CT 6 30mEq L 7 8 1 2 1 2 W PD 2 1 5 2 5 PD 2 4 25 2 3 CAPD 4
34. 2 1 2 3 4 5 2 HCa1 5 HCa 2 5 a 0 mL 362 544 725 906 1812 362 544 725 906 1812 725 g 13 6 20 4 27 2 34 0 68 0 122 7 34 1 45 4 56 7 113 4 772 C H zO 1 12 1 68 2 24 2 80 5 60 1 12 1 68 2 24 2 80 5 60 2 24 CaHNaO 0 257 0 386 10 515 10 643 1 287 0 257 0 38610 515 0 643 1 287 0 515 CaCL 2H 0 0 05110 07610 10210 127 0 254 0 051 0 076 0 10210 127 0 254 0 102 MgCb 6H 0 2 21 3 32 4 42 5 53 11 05 2 21 3 32 4 42 5 53 11 05 4 42 NaCD HCD 0 190 0 286 0 38110 476 0 953 0 190 10 286 0 38110 476 0 953 0 381 mL 638 956 1275 1594 13188 638 956 1275 1594 3188 1275 g 2 31 3 46 4 62
35. 89 3 86w v VII 1 2 3 4 5 6 1 2 3 4 5 6 7 1 2 3 4 5 1 2 CYP450 3 4 5
36. HCa 1 5 HCa 2 5 UV UV 1 000mL 6 O 1 500mL 5 QO 2 000mL 4 LCa 1 5 2 5 4 25 W PD 2 1 5 2 5 PD 2 4 25 PD 4 1 5 2 5 PD 4 4 25 2003 1 8 rm 2013 9 20 22500AMX01821000 a 2013 9 20 22500AMX01823000 a 2013 9 20 22500AMX01822000 2013 11 29 12 13 14 15
37. JAN JAN ATB3415 HCa 1 5 oon 456509607 4987456509607 5 HCa 1 5 AIB3518 1 500mL 456509485 4987456509485 5 ATg3411 HCa 1 5 9o0omL 456509560 4987456509560 6 HCa 1 5 MS 1 000mL 456509447 4987456509447 6 HCa 1 5 UM 2 500mL 456509409 4987456509409 4 ATB3416 HCa 1 5 000mL 456509645 4987456509645 4 HCa 1 5 AB3616 ES 2 000mL 456509522 4987456509522 4 HCa 1 5 ANB3619 5 000mL 456509355 4987456509355 2 ATg3425 HCa 2 5 500mL 456509621 4987456509621 5 HCa 2 5 NB3520 1 500mL 456509508 4987456509508 5 ATB3421 HCa 2 5 nomL 456509584 4987456509584 6 HCa 2 5 Ucar 1 000mL 456509461 4987456
38. HCO HCO 1 3 5mEq L 2 25mEq L 10mEq L 3
39. ES PMB 13 2 25mg L 6 1 100mg L 2270IU L 0 i a 14 1 100mg L ik DI 100mg L 0 125mg L 2270UM _ a 125mg L 15 1 250mg L NN 22701U L 250mg L 9 1 E 125mg L Fh EMU 125mg7L 1 mg L 9 22Y020 ME _ RNN mg 2 x 4mg L 3 9 2 Lino RO Ca 4 25 pH 2 6 12 24
40. 20 1 2 5 ee 20 2 2 6 21 3 OR NO 2 7 81 7885 18iS 22 4 REE RR 8 8 ERNIE RE RR REE SERRE RR REDE ERRES EE 5 1831605 03806 8618 081185SCRU8I392 2 9 08660808I 61878e8 88885 26 6 PTT 2 10 WR ER RE 26 7 CAS eiseeeseeeeeeeeeeeseeeeeteeeeees 2 11 omoro 26 12 26 ieeeeeeeeeeeeeeeseeeeeeeee 3 13 oo 26 1 WR EERE EEE EEE SEER EEE 3 14 RRR ER ERE ENE ERED RE ERE 26 2 RARER 4 15 DER ERR RR RTE RR EERE 26 3 BRERA EI EE ES 4 16 RRA RE EE ERE ER ERE Et 26 4 ROR RR EER RR NE RR RR 4 IX ecceeeeeeeeeeeeeeeeeee 27 IV
41. ls1 pH 7 40 7 54 7 50 7 48 7 67 a 20 5 206 199 181 110 100 oo5 971 883 53 7 1 2 pH 7 46 7 51 7 52 7 57 7 66 19 8 20 1 19 3 17 6 7 8 100 101 5 97 5 88 9 39 4 101 5 2 1 pH 7 44 7 48 7 54 7 55 7 64 123 4 122 8 120 2 117 3 113 0 100 og 5 97 4 95 1 91 6 ag 2 2 pH 7 44 7 50 7 56 7 62 7 61 a 120 9 1212 123 5 1194 118 2 100 100 2 102 2 98 8 97 8 100 2 3 1 pH 7 45 7 57 7 57 7 58 7 57 EE 204 0 1970 202 3 178 8 125 2 100 96 6 99 2 87 6 61 4
42. 016 CAPD 12 6 REG 042 CA 2 as BLR350 APD 2 6 HCO 50 1 CAPD 2 APD 3 BLBC 25mEq L 15mEq L 29 CAPD 97 BLR350 47 PD 2 50 PD 2 1 3 5 2L 8 1 PD 2 0 12 0 84 L 1 73mz 95 1 78 1 55 L 1 73mz 3 2 L 1
43. 2 1 2 3 4 VI 77 vitro PD 2 MTT IL 1 3 IL 6 MTT IL 6 viability PD 2 PD 2
44. 95 0 amp 3 52 6 gt 53 2 w 38 44 pH INR2 22 CiH NaO 5g 50mL pH 4 8 5 8 pH 1 0g 20mL pH 4 5 9 2 a pH 1 0g 20mL pH 5 0 7 0 1 0g 20mL pH 7 9 8 4
45. IF 2008 IF 2008 IF PDF e IF e IF e IF http www info pmda go jp NSR e IF e IF IF 2008 4
46. IF A4 9 IF IF 2 IF IF IF IF IF 2013 IF
47. 1 66 0 28 PD 2 1 70 0 33 1 66 0 30 1 71 0 28 4 HCO PD 2 1 34 0 35 mEq L 95 2 04 0 64 mEq L HCO PD 2 p lt 0 001 2 4 8 12 26 52 2 80 28 55 2 63 27 10 2 84 28 42 2 49 27 57 2 94 PD 2 28 25 2 95 28 63 3 05 28 06 3 04 mEq L 3 4 5 6 5 Na K CI Ca Mg P 2 4 8 12 eu 138 4 3 3 138 2 3 6 Ne 1393432 3 3 138 8 3 3 0 Es 4 17 0 65 Nt 4 24 0 72 2 ee SG a DD _ Bs 96 3 4 0 Pe 96 3 3 7 7 gz41 ei 97 5 4 0 _ a 4 780 47 2720038 4 74 0 38 4 65 0 36 et 4 73 0 31 mEq 2 21 0 39 2220039 2 18 0 36 2 12 0 33 NN 2 13 0 36 50641 20 mm 5 321 22
48. 10 0 Vl 8 1 1 2 3 2 1 2 3 3 4 5 6 7 CAS HCa 1 5 HCa 2 5 HCa 4 25 Reguneal HCa 1 5 Peritoneal Dialysis Solution Reguneal HCa 2 5 Peritoneal Dialysis Solution Reguneal HCa 4 25 Peritoneal Dialysis Solution Regulate peritoneaU 1 5 2 5 4 25 1 36w v 2 27 w v 3 86 w v CH CH COONa
49. 5 6 7 8 9 10 11 12 13 20 6 14 15 16
50. 5 99 2 2 1 pH 7 48 7 44 7 54 7 56 7 56 EE 3 5 3 5 3 4 3 3 3 1 oo oo 97 1 94 3 88 6 5 pH 740 753 254 759 763 RR 3 9 3 8 3 4 3 4 3 1 Go 974 87 2 87 2 79 5 99 2 10 1 pH 7 47 7 49 7 54 7 64 7 57 a 2566 252 5 255 1 228 6 186 5 100 98 4 99 4 89 1 72 7 2 6 12 24 10 2 pH 7 43 7 45 7 70 7 63 7 60 a 2 d25 155 8 062 99 0
51. 2 4 0 100 1 1 2 0 1 1 2 0 _ _ 1 1 2 0 lO 1 1 2 0 30 19 38 0 eo 2 21 40 8B 2 2 4 0 2 2 40 1 1 2 0 2 2 4 0 _ 1 1 2 0 pH _ _ _ 1 1 2 0 1 2 0 a 2 2 4 0 _ _ 20 1 1 2 0 a 24 MedDRA Ver 14 1 BLR 350 50 REG 042 40 CUST 016 9 REG 043 50 C 4 4 8 0 4 4 8 0 1 1 2 0 7 7 14 0 1 1 2 0 1 1 2 0 8 8 16 0 2 2 4 0 1 1 2 0 1 1 2
52. 9 1 11 1 1 REG 043 3 50 9 18 0 15 MedDRA BLR 350 REG 042 CUST 016 REG 043 Ver 14 1 50 40 9 50 Z426 52 0 5 4 0 0 II IT 00DIIISS9 80 50 1 1 2 0 1 1 1 2 0 0 ONO 1 1 2 0 1 1 2 0 23 6 BLR 350 REG 042 CUST 016 REG 043 Ver 14 1 50 40 9 50 _ 2 O03 75 20 _ 1 1 2 0 5 5 10 0 3 2 4 0 1 1 2 0 2 1 2 0 1 1 2 5 11 11 _ _ 22 0 2 2 4 0 1 1 2 0 Tl 255 1 1 2 5
53. 2013 IF PDF IF IF 2013 25 10 IF 2013 IF 3 IF IF 2013 PDF IF
54. 5 200mL kg 200mL kg 05 10 1 5 50mL kg 28 28 50mL kg IX 2 2
55. 1980 2 BLR 350 3 Pyle W K et al Peritoneal transport evaluation in CAPD In edited by Moncrief W et al CAPD Update 35 52 Masson Publishing USA 1981 4 CAPD CAPD 5 17 1984 5 Nolph K D et al Multicenter evaluation of new peritoneal dialysis solution with a high lactate and a low magnesium concentration Peritoneal Dialysis Bulletin 3 2 63 65 1983 6 Mandelbaum M et al Six month s experience with PD 2 solution Dialysis and Transplantation 12 4 259 260 1983 7 Heimburger O et al Buffer transport in peritoneal dialysis Kidney International 64 SuppL88 S37 42 2003 8 5 6 9 CAPD 149 163 1984 10 sclerosing encapsulating peritonitis SEP 1995 29 2 155 163 1996 11 REG 042 12
56. 12 10 31 4 ERR RR ER EAR RR ER UE RR EU 12 11 31 12 V oo 13 32 1 ee 13 13 2 13 SEES RR RR RR ERR 32 3 WR SRE EE EE EEE ESE REESE EE 14 14 SERRE RA EE RE RR UE EE EE 32 15 32 VI oeoeoeooooooe 17 16 HERE EE REE RRR UE EEE RE 32 1 17 17 ee 32 2 17 4 4 SSCCGUCULUUTETTEPETTECETTEFPTCEFPTTEFPTTITTP 33 VII PPPCPCTPTYTTTTTYTYTTTYYTTYYYYYYD 18 1 PT 33 1 DER RR RS TERT RR TE RR 18 2 SER RE SERENE NRE ER EER RE SE 33 2 RE RR RR ERE 18 3 i 18 X eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee 34 4 RRR
57. 2013 9 20 6 ES 2013 11 29 TEL 03 6204 3700 FAX 03 6204 3701 9 17 IF 2013 9 http www info pmda go jp Baxter Reguneal Baxter IF 1 2
58. CUST 016 13 REG 043 14 15 16 33 XII 1 VIAFLEX 22 2011 6 2003 1 8 Physioneal 35 2003 8 14 Physioneal 35 2003 10 10 Physioneal 35 2003 10 29 Physioneal 35 2003 11 12 Physioneal 35 2003 11 12 Physioneal 35 2003 11 12 Physioneal 35 2003 11 12 Physioneal 35 2003 12 3 Physioneal 35 2003 12 4 Physioneal 35 2004 1 9 Physioneal 35 2004 1 15 Physioneal 35 2004 3 17 Physioneal 35 2004 3
59. 2 1 2 3 1 4mEq L 26 IX 1 1 2 3 4
60. 1 Physioneal 35 2004 6 15 Physioneal 35 2004 8 25 Physioneal 35 2005 4 27 Physioneal 35 2005 7 19 Physioneal 35 2007 3 1 Physioneal 35 2007 3 16 Physioneal 35 2009 11 6 Physioneal 35 2011 5 12 Physioneal 35 CLEARFLEX 18 2011 6 Baxter Healthcare Corporation Physioneal 35 1 36 w v 13 6mg mL CLEARFLEX Physioneal 35 2 27 w v 22 7mg mL CLEARFLEX Physioneal 35 3 86 w V 38 6mg mL CLEARFLEX 2003 10 24 CAPD 1 24 4 APD 4 5 2
61. 2 1 2 3 4 5 a nas0 BLR350 CAPD 8 113 BLBC 3 CAPD 12 106 cc 4 I BLBC CAPD 8 59 ceo4 gt BLR350 CAPD 8 HCO 42 I b BLR350 Cust
62. 2 1 IV 1 2 m 2 pH Ca HCa HCa pH 1 5 2 5 4 25 pH 3 2 3 8 8 8 9413 2 3 8 8 8 9 413 2 3 8 8 8 9 4 HCa HCa HCa 1 5 2 5 4 25 pH 6 8 7 8 6 8 7 8 6 8 7 8 346 396 484 11 12 1 3 1 4 1 6 1 8 3
63. 234 6 196 2 179 7 173 2 oo 101 0 84 5 77 4 74 6 98 1 1 2 3 2 2
64. 5 77 11 54 2 31 3 46 4 62 5 77 11 54 4 62 NaHCO 3 15 4 72 6 30 7 87 115 75 3 15 4 72 6 30 7 87 15 75 6 30 NaCD 0 113 0 169 0 225 0 281 0 562 10 113 0 169 0 225 0 281 0 562 0 225 NaOH mL 1000 1500 2000 2500 15000 1000 1500 12000 2500 5000 2000 w V 1 36 2 27 3 86 HCa HCa HCa 1 5 2 5 4 25 Na 132 mEq L Ca 3 5 mEq L Mg 0 5 mEq L CC 101 mEq L HCOs 25 mEq L 10 mEq L 25 2 C 40 5 RH 24 5 HMF 40 2 C 20 5 RH 6
65. 73m2 4 8 12 48 87 9 60 50 82 9 03 49 69 9 25 50 0810 55 49 09 9 55 gt PD 2 50 10 9 67 49 15 10 01 49 62 10 19 L 1 73m2 2 PD 2 0 125 0 051 L 95 0 023 0 227 L 0 12 L 4 8 12 0 764 0 572 lt 0 747 0 475 0 838 0 457 0 862 0 476 0 687 0 378 PD 2 0 739 0 394 0 688 0 374 0 746 0 385 L 3 PD 2 0 040 03 95 0 02 0 09 PD 2 4 8 12 1 67 0 37 gt 1 67 0 33 1 69 0 36 1 72 0 39
66. PCOPPPPYTYYTTTYYTYTYTYTYYTYYYYYTYYTYTYTYTYY 5 6 Pr 1 27 1 0838808I88IS538e78 iP38Ii13168SCYWRGSGIGSIEIS Mie76E 5 2 61 UI 981829SD8298 6 3IeW8S8i8le 99591818 68518 p8i525 6 3 i q tr re 7 X oil 29 4 ERE EERE RS 7 1 ENE REE E ERREREREREEEEESE IERTEEE IERER 29 5 EEE EER 7 RR RE ER EE 29 6 wisisassuseais eas ise us 7 3 TT 29 POCKET 8 4 WEA ER 29 8 VT 12 5 TT 30 9 RR RE 12 6 WRENN RR RE RR ERE RERUN ER 31 10 sass ues tse 12 7 31 11 PITT TT TT 12 8 PT 31 12 888898378S1898i08 12 9 ST Wi187808I8 88708i81878SS 6 31 13
67. REE EE ER RE RE REERAEE Sa 18 1 KASS RRS th RE Rt ts 34 5 ERR EER RE EE RRNA 18 2 RRR ERE UA EEE 35 6 RR EE EEE EE ER UE RE EEE 19 7 RR RR RR 19 XIH eccsecceceeecececcesecesceceseseesccecseseecececeeeeeee 36 8 RE RE ER 19 36 1 2 W
68. at 497 1 18 2e 5 081 24 mg dL 2 BLR 350 1 2 V 3 2 50 26 52 0 74 PD 2 54 19 35 2 67 Fisher P 0 113 3 4 1 2 VI 1 2 3 HCa 1 5 2 5 4 25
69. 0 6 6 12 0 0 1 1 2 0 Ri A0 2 2 4 0 1 1 2 0 Ts TG 0 1 1 2 0 CD 1 2 80 1 G0 ls 1 C5 3 2 4 0 1 1 2 5 2 1 2 0 1 1 2 0 1 1 2 0 2 2500 1 1 2 0 1 1 2 0 20 1 1 2 0 IN Ii200 1 1 2 0 0 AO 1 1 2 0 1 1 2 0 10 11 12 13 3 14 15 16 5 6
70. 2013 11 1 87342 IF 2013 HCa 1 5 HCa 2 5 HCa 4 25 Reguneal HCa 1 5 2 5 4 25 Peritoneal Dialysis Solution 4 Ca 1 5 HCa 1 5 2 500mL 1 1 000mL 1 5 000mL 1 1 500mL 1 a HCa 2 5 2 000mL 1 2 500mL 1 HCa 2 5 5 000mL 1 1 000mL 1 HCa 4 25 1 500mL 1 2 000mL 1 2 000mL 1
71. 509461 6 HCa 2 5 NN ye MR ope 2 500mL 456509423 4987456509423 4 HCa 2 5 ATB3426 2 000mL 456509669 4987456509669 4 HCa 2 5 MD eS 2 000mL 456509546 4987456509546 4 HCa 2 5 AINB629 DR 5 000mL 456509379 4987456509379 2 ATB3636 HCa 4 25 ooomL 45e509348 4987456509348 4 36 38 39 Baxter 8 10 03 6204 3700 ON 1311
Download Pdf Manuals
Related Search